Leading myeloma specialists from across Europe recently published an article in the journal The Oncologist that summarized the current treatment options and availability of therapeutic agents for multiple myeloma patients in Europe. This article, Part 4 in the series, summarizes the European authors’ recommendations for the management of side effects.

The European authors provided recommendations for managing side effects related to novel agent use in myeloma patients. The recommendations are similar to how the side effects are managed in the United States.

Blood Clots

Blood clots are one of the …